Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rinsho Ketsueki ; 51(4): 281-5, 2010 Apr.
Artigo em Japonês | MEDLINE | ID: mdl-20467226

RESUMO

A 51-year-old woman developed very severe aplastic anemia complicated by chronic renal failure. She underwent ATG therapy, resulting in a transient effect. Thereafter, renal insufficiency progressed, followed by the induction of CAPD therapy. Although rabbit ATG (rATG) was administered as the next immunotherapy for aplastic anemia, pancytopenia persisted and she experienced repeated episodes of severe infection including MRSA and fungal infections. She was transplanted with peripheral blood stem cells from her HLA-haploidentical son after a reduced-intensity conditioning regimen that included cyclophosphamide (three days of 30 mg/kg), fludarabine (two days of 20 mg/m(2)) and rATG (three days of 2.5 mg/kg). FK506 (0.03 mg/kg/24H) was administered for the prophylaxis of GVHD. Prompt trilineage engraftment occurred, resulting in the improvement of infections. Three months after grafting, she succumbed to cerebrovascular disease, although there was no apparent GVHD and she had remained well with stable hematopoiesis.


Assuntos
Anemia Aplástica/terapia , Sobrevivência de Enxerto , Antígenos HLA/genética , Haploidia , Transplante de Células-Tronco de Sangue Periférico , Diálise Peritoneal Ambulatorial Contínua , Animais , Soro Antilinfocitário/administração & dosagem , Ciclofosfamida/administração & dosagem , Feminino , Humanos , Imunossupressores/administração & dosagem , Pessoa de Meia-Idade , Núcleo Familiar , Coelhos , Índice de Gravidade de Doença , Tacrolimo/administração & dosagem , Condicionamento Pré-Transplante , Vidarabina/administração & dosagem , Vidarabina/análogos & derivados
2.
Rinsho Ketsueki ; 50(2): 113-5, 2009 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-19265306

RESUMO

A 74-year-old man was hospitalized with hypoglossal nerve paralysis and severe great occipital neuralgia. Enhanced MRI of the head showed tumor on the left petrous bone, which compressed the medulla oblongata. Soluble IL-2 receptor was elevated and malignant lymphoma was clinically diagnosed. PET-CT demonstrated a single hot spot on the spleen. After radiation therapy to the lesion on the petrous bone, splenectomy was performed. Pathological findings established a diagnosis of diffuse large B-cell lymphoma. After chemotherapy consisting of rituximab and THP-COP, complete remission was achieved.


Assuntos
Doenças do Nervo Hipoglosso/etiologia , Linfoma Difuso de Grandes Células B/complicações , Neoplasias Primárias Múltiplas , Neuralgia/etiologia , Osso Occipital/inervação , Osso Petroso , Neoplasias Cranianas/complicações , Idoso , Biomarcadores Tumorais/sangue , Terapia Combinada , Humanos , Linfoma Difuso de Grandes Células B/diagnóstico , Linfoma Difuso de Grandes Células B/terapia , Masculino , Receptores de Interleucina-2/sangue , Indução de Remissão , Neoplasias Cranianas/diagnóstico , Neoplasias Cranianas/terapia , Neoplasias Esplênicas/complicações , Neoplasias Esplênicas/diagnóstico , Neoplasias Esplênicas/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA